Last November, Novo Nordisk announced it would stop selling the injectable FlexPen version of Levemir this month and halt sales of Levemir vials by December 2024. The decision to discontinue ...

Levemir (insulin detemir) is a brand-name injection that’s prescribed for diabetes. Levemir has interactions with alcohol, some other drugs, and certain supplements. Examples include beta ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir, arguing that it could leave some diabetics without an ...

Novo Nordisk is discontinuing one of its discounted insulin brands, Levemir, because of manufacturing issues, decreasing patient coverage, and the availability of alternative treatments.